<h1 id="anaphylaxis">Anaphylaxis</h1>
<p><strong>Definition</strong>: A serious allergic reaction that is rapid in onset and might cause death</p>
<p><strong>Mechanism</strong>: IgE-mediated immune reaction</p>
<p><strong>Pearl</strong>: Hypotension is NOT required to diagnose anaphylaxis.</p>
<p><strong>Triggers</strong>: Almost any food, allergens, or medications can be a trigger.</p>
<p><strong>Common culprits</strong>:</p>
<ul>
<li>Antibiotics (especially beta-lactams)</li>
<li>NSAIDs</li>
<li>Peanuts</li>
<li>Shellfish</li>
</ul>
<p><strong>Organ involvement</strong>: Skin 80-90%, Resp 70%, GI 45%, CV 45%, CNS 15%</p>
<p><strong>Biphasic anaphylaxis pattern</strong>: 2nd flare may occur despite trigger removed (typically within 72 hours of onset)</p>
<h2 id="diagnostic-criteria">Diagnostic criteria</h2>
<blockquote>
<p>Highly likely if <strong>1 or 3 criteria</strong> fulfilled per 2nd National Institute of Allergy and ID/Food Allergy and Anaphylaxis Network</p>
</blockquote>
<ol>
<li><p>Acute onset (min-several hrs), involving skin, mucosa, or both (hives, flushing, pruritis, angioedema) AND at least 1 of the following:</p>
<ul>
<li>Respiratory compromise: shortness of breath, wheezing, stridor, hypoxemia, reduced PEF</li>
<li>Reduced BP or associated sx of end-organ dysfunction: hypotonia, syncope, incontinence</li>
</ul>
</li>
<li><p>Two or more of the following that occur rapidly after exposure to likely allergen:</p>
<ol>
<li>Involvement of skin-mucosal tissue: hives, itching, flushing</li>
<li>Respiratory compromise: shortness of breath, wheezing, stridor, hypoxema, reduced PEF</li>
<li>Reduced BP or associated dx: hypotonia, syncope, incontinence</li>
<li>Persistent GI sx: cramping, abdominal pain, vomiting</li>
</ol>
</li>
<li><p>Reduced BP after exposure to known allergen</p>
<ul>
<li><p>Infants/children: Low SBP (age specific) or &gt; 30% decrease in SBP</p>
<ul>
<li>Age 1 mo - 1 yr: SBP &lt; 70 mmHg</li>
<li>Age 1 yr - 10 yr: SBP &lt; 70 mmHg + [2 x age]</li>
</ul>
</li>
<li><p>Adults: SBP &lt;90 mmHg or &gt;30% decrease in person&#39;s baseline</p>
</li>
</ul>
</li>
</ol>
<h2 id="ed-management">ED management</h2>
<ul>
<li>Supine position, ABCs</li>
<li><strong>IM <span class="drug">epinephrine</span> STAT</strong>. Repeat every 5-15 min if refractory<ul>
<li>0.3-0.5 mg for adults = 0.3-0.5 mL 0f 1:1000 concentration of epinephrine</li>
<li>0.15 mg for patient wt &lt; 30 kg</li>
<li><strong>IM injection into lateral thigh</strong> - quickest absorption centrally</li>
</ul>
</li>
<li>IV fluids 2 liters</li>
<li>H1 antagonist (eg. <span class="drug">diphenhydramine</span>)</li>
<li>H2 antagonist ( eg. <span class="drug">ranitidine</span>)</li>
<li>Glucocorticoids (eg. <span class="drug">Methylprednisolone</span>; may blunt biphasic response)</li>
<li><span class="drug">Albuterol</span> (beta-agonist) nebulizer for wheezing/lower airway obstruction</li>
<li>Consider: <span class="drug">Glucagon</span> 3.5-5 mg IV if refractory to epinephrine and on beta-blockers</li>
<li>If discharging patient home after observation, <strong>prescribe <span class="drug">epinephrine pen</span></strong></li>
</ul>
<h2 id="references">References</h2>
<ul>
<li><a href="http://www.ncbi.nlm.nih.gov/pubmed/20176258">Simons FER. J Allergy Clin Immunol 2010;125:S161-81.</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/pubmed/22085665">Arnold JJ, Williams PM. Amer Fam Phys 2011; 84(10):1111-8.</a></li>
</ul>
